Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Jul;74(1):133–140. doi: 10.1038/bjc.1996.328

Glycolipids of human primary testicular germ cell tumours.

R A Olie 1, B Fenderson 1, K Daley 1, J W Oosterhuis 1, J Murphy 1, L H Looijenga 1
PMCID: PMC2074619  PMID: 8679447

Abstract

The glycolipid content of human non-seminomatous germ cell tumour cell lines correlates with their differentiation lineage. To analyse whether this reflects the situation in primary tumours, we studied five embryonal carcinomas, five yolk sac tumours and nine (mixed) non-seminomas, using thin-layer chromatography and carbohydrate immunostaining. We also analysed the glycolipid content of 19 seminomas to reveal their relationship with non-seminomas. Lactosylceramide (CDH) was detected in all embryonal carcinomas, but in fewer than half of the seminomas. Seminomas and embryonal carcinomas contained globoseries glycolipids, including globotriosylceramide (Gb3), globoside (Gb4), galactosy globoside (Gb5) and sialy1 galactosyl globoside (GL7). The lacto-series glycolipid Le(x) was found in all embryonal carcinomas, but only in one seminoma. Gangliosides GD3 and GT3 were detected in many seminomas, but rarely in embryonal carcinomas. Yolk sac tumours displayed a heterogeneous glycolipid profile. Compared with seminomas and pure embryonal carcinomas, differentiated non-seminomas had reduced levels of globo-series glycolipids, especially Gb3 and Gb5, whereas CDH, Le(x), GD3 and GT3 were found in the majority of cases. Thus, the glycolipid content of non-seminoma cell lines reflects the situation in primary tumours. Globo-series glycolipids are similarly expressed in seminomas and embryonal carcinomas. The expression of Gb3 and Gb5 is reduced in non-seminomas upon differentiation. Le(x) expression in non-seminomas, including embryonal carcinomas, allows discrimination from seminomas. Expression of gangliosides in seminomas might indicate their maturation from ganglioside-negative precursor cells. Reprogramming of these precursors would result in the formation of Le(x)-expressing embryonal carcinomas.

Full text

PDF
133

Images in this article

135Figure 1
on p.135
136Figure 2
on p.136

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. W., Bronson D. L., Benham F., Strickland S., Knowles B. B. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int J Cancer. 1980 Sep 15;26(3):269–280. doi: 10.1002/ijc.2910260304. [DOI] [PubMed] [Google Scholar]
  2. Andrews P. W., Nudelman E., Hakomori S., Fenderson B. A. Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR). Differentiation. 1990 Apr;43(2):131–138. doi: 10.1111/j.1432-0436.1990.tb00439.x. [DOI] [PubMed] [Google Scholar]
  3. Bird J. M., Kimber S. J. Oligosaccharides containing fucose linked alpha(1-3) and alpha(1-4) to N-acetylglucosamine cause decompaction of mouse morulae. Dev Biol. 1984 Aug;104(2):449–460. doi: 10.1016/0012-1606(84)90101-5. [DOI] [PubMed] [Google Scholar]
  4. Bremer E. G., Hakomori S., Bowen-Pope D. F., Raines E., Ross R. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem. 1984 Jun 10;259(11):6818–6825. [PubMed] [Google Scholar]
  5. Casper J., Schmoll H. J., Schnaidt U., Fonatsch C. Cell lines of human germinal cancer. Int J Androl. 1987 Feb;10(1):105–113. doi: 10.1111/j.1365-2605.1987.tb00171.x. [DOI] [PubMed] [Google Scholar]
  6. Cuello A. C., Garofalo L., Kenigsberg R. L., Maysinger D. Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons. Proc Natl Acad Sci U S A. 1989 Mar;86(6):2056–2060. doi: 10.1073/pnas.86.6.2056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cummings O. W., Ulbright T. M., Eble J. N., Roth L. M. Spermatocytic seminoma: an immunohistochemical study. Hum Pathol. 1994 Jan;25(1):54–59. doi: 10.1016/0046-8177(94)90171-6. [DOI] [PubMed] [Google Scholar]
  8. Czaja J. T., Ulbright T. M. Evidence for the transformation of seminoma to yolk sac tumor, with histogenetic considerations. Am J Clin Pathol. 1992 Apr;97(4):468–477. doi: 10.1093/ajcp/97.4.468. [DOI] [PubMed] [Google Scholar]
  9. Czernobilsky B. Differentiation patterns in human testicular germ cell tumours. Virchows Arch A Pathol Anat Histopathol. 1991;419(2):77–78. doi: 10.1007/BF01600219. [DOI] [PubMed] [Google Scholar]
  10. Damjanov I., Fox N., Knowles B. B., Solter D., Lange P. H., Fraley E. E. Immunohistochemical localization of murine stage-specific embryonic antigens in human testicular germ cell tumors. Am J Pathol. 1982 Aug;108(2):225–230. [PMC free article] [PubMed] [Google Scholar]
  11. Damjanov I., Horvat B., Gibas Z. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT. Lab Invest. 1993 Feb;68(2):220–232. [PubMed] [Google Scholar]
  12. Dippold W. G., Knuth A., Meyer zum Büschenfelde K. H. Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody. Cancer Res. 1984 Feb;44(2):806–810. [PubMed] [Google Scholar]
  13. Eggens I., Fenderson B., Toyokuni T., Dean B., Stroud M., Hakomori S. Specific interaction between Lex and Lex determinants. A possible basis for cell recognition in preimplantation embryos and in embryonal carcinoma cells. J Biol Chem. 1989 Jun 5;264(16):9476–9484. [PubMed] [Google Scholar]
  14. Eisenbarth G. S., Walsh F. S., Nirenberg M. Monoclonal antibody to a plasma membrane antigen of neurons. Proc Natl Acad Sci U S A. 1979 Oct;76(10):4913–4917. doi: 10.1073/pnas.76.10.4913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. FOLCH J., ARSOVE S., MEATH J. A. Isolation of brain strandin, a new type of large molecule tissue component. J Biol Chem. 1951 Aug;191(2):819–831. [PubMed] [Google Scholar]
  16. FRIEDMAN N. B. The comparative morphogenesis of extragenital and gonadal teratoid tumors. Cancer. 1951 Mar;4(2):265–276. doi: 10.1002/1097-0142(195103)4:2<265::aid-cncr2820040211>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  17. Fenderson B. A., Andrews P. W., Nudelman E., Clausen H., Hakomori S. Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev Biol. 1987 Jul;122(1):21–34. doi: 10.1016/0012-1606(87)90328-9. [DOI] [PubMed] [Google Scholar]
  18. Fenderson B. A., Radin N., Andrews P. W. Differentiation antigens of human germ cell tumours: distribution of carbohydrate epitopes on glycolipids and glycoproteins analyzed using PDMP, an inhibitor of glycolipid synthesis. Eur Urol. 1993;23(1):30–37. doi: 10.1159/000474567. [DOI] [PubMed] [Google Scholar]
  19. Fenderson B. A., Zehavi U., Hakomori S. A multivalent lacto-N-fucopentaose III-lysyllysine conjugate decompacts preimplantation mouse embryos, while the free oligosaccharide is ineffective. J Exp Med. 1984 Nov 1;160(5):1591–1596. doi: 10.1084/jem.160.5.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Fosså S. D., Nesland J. M., Pettersen E. O., Amellem O., Waehre H., Heimdal K. DNA ploidy in primary testicular cancer. Br J Cancer. 1991 Nov;64(5):948–952. doi: 10.1038/bjc.1991.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gillis A. J., Oosterhuis J. W., Schipper M. E., Barten E. J., van Berlo R., van Gurp R. J., Abraham M., Saunders G. F., Looijenga L. H. Origin and biology of a testicular Wilms' tumor. Genes Chromosomes Cancer. 1994 Oct;11(2):126–135. doi: 10.1002/gcc.2870110209. [DOI] [PubMed] [Google Scholar]
  22. Gooi H. C., Feizi T., Kapadia A., Knowles B. B., Solter D., Evans M. J. Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature. 1981 Jul 9;292(5819):156–158. doi: 10.1038/292156a0. [DOI] [PubMed] [Google Scholar]
  23. Kang J. L., Rajpert-De Meyts E., Wiels J., Skakkebaek N. E. Expression of the glycolipid globotriaosylceramide (Gb3) in testicular carcinoma in situ. Virchows Arch. 1995;426(4):369–374. doi: 10.1007/BF00191346. [DOI] [PubMed] [Google Scholar]
  24. Kannagi R., Cochran N. A., Ishigami F., Hakomori S., Andrews P. W., Knowles B. B., Solter D. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J. 1983;2(12):2355–2361. doi: 10.1002/j.1460-2075.1983.tb01746.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kannagi R., Levery S. B., Ishigami F., Hakomori S., Shevinsky L. H., Knowles B. B., Solter D. New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J Biol Chem. 1983 Jul 25;258(14):8934–8942. [PubMed] [Google Scholar]
  26. Kannagi R., Nudelman E., Levery S. B., Hakomori S. A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1. J Biol Chem. 1982 Dec 25;257(24):14865–14874. [PubMed] [Google Scholar]
  27. Looijenga L. H., Gillis A. J., Van Putten W. L., Oosterhuis J. W. In situ numeric analysis of centromeric regions of chromosomes 1, 12, and 15 of seminomas, nonseminomatous germ cell tumors, and carcinoma in situ of human testis. Lab Invest. 1993 Feb;68(2):211–219. [PubMed] [Google Scholar]
  28. Mostofi F. K. Pathology of germ cell tumors of testis: a progress report. Cancer. 1980 Apr 15;45(7 Suppl):1735–1754. [PubMed] [Google Scholar]
  29. Mostofi F. K., Sesterhenn I. A., Davis C. J., Jr Immunopathology of germ cell tumors of the testis. Semin Diagn Pathol. 1987 Nov;4(4):320–341. [PubMed] [Google Scholar]
  30. Motzer R. J., Reuter V. E., Cordon-Cardo C., Bosl G. J. Blood group-related antigens in human germ cell tumors. Cancer Res. 1988 Sep 15;48(18):5342–5347. [PubMed] [Google Scholar]
  31. Ohyama C., Fukushi Y., Satoh M., Saitoh S., Orikasa S., Nudelman E., Straud M., Hakomori S. Changes in glycolipid expression in human testicular tumor. Int J Cancer. 1990 Jun 15;45(6):1040–1044. doi: 10.1002/ijc.2910450610. [DOI] [PubMed] [Google Scholar]
  32. Ohyama C., Orikasa S., Satoh M., Saito S., Ohtani H., Fukushi Y. Globotriaosyl ceramide glycolipid in seminoma: its clinicopathological importance in differentiation from testicular malignant lymphoma. J Urol. 1992 Jul;148(1):72–75. doi: 10.1016/s0022-5347(17)36513-8. [DOI] [PubMed] [Google Scholar]
  33. Olie R. A., Looijenga L. H., Boerrigter L., Top B., Rodenhuis S., Langeveld A., Mulder M. P., Oosterhuis J. W. N- and KRAS mutations in primary testicular germ cell tumors: incidence and possible biological implications. Genes Chromosomes Cancer. 1995 Feb;12(2):110–116. doi: 10.1002/gcc.2870120205. [DOI] [PubMed] [Google Scholar]
  34. Olie R. A., Looijenga L. H., Dekker M. C., de Jong F. H., van Dissel-Emiliani F. M., de Rooij D. G., van der Holt B., Oosterhuis J. W. Heterogeneity in the in vitro survival and proliferation of human seminoma cells. Br J Cancer. 1995 Jan;71(1):13–17. doi: 10.1038/bjc.1995.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Oliver R. T. Clues from natural history and results of treatment supporting the monoclonal origin of germ cell tumours. Cancer Surv. 1990;9(2):333–368. [PubMed] [Google Scholar]
  36. Oliver R. T. HLA phenotype and clinicopathological behaviour of germ cell tumours: possible evidence for clonal evolution from seminomas to nonseminomas. Int J Androl. 1987 Feb;10(1):85–93. doi: 10.1111/j.1365-2605.1987.tb00169.x. [DOI] [PubMed] [Google Scholar]
  37. Oosterhuis J. W., Looijenga L. H. The biology of human germ cell tumours: retrospective speculations and new prospectives. Eur Urol. 1993;23(1):245–250. doi: 10.1159/000474601. [DOI] [PubMed] [Google Scholar]
  38. Oosterhuis J. W., de Jong B., van Dalen I., van der Meer I., Visser M., de Leij L., Mesander G., Collard J. G., Schraffordt Koops H., Sleijfer D. T. Identical chromosome translocations involving the region of the c-myb oncogene in four metastases of a mediastinal teratocarcinoma. Cancer Genet Cytogenet. 1985 Feb 1;15(1-2):99–107. doi: 10.1016/0165-4608(85)90136-0. [DOI] [PubMed] [Google Scholar]
  39. Pera M. F., Blasco Lafita M. J., Mills J. Cultured stem-cells from human testicular teratomas: the nature of human embryonal carcinoma, and its comparison with two types of yolk-sac carcinoma. Int J Cancer. 1987 Sep 15;40(3):334–343. doi: 10.1002/ijc.2910400309. [DOI] [PubMed] [Google Scholar]
  40. SVENNERHOLM L. THE GANGLIOSIDES. J Lipid Res. 1964 Apr;5:145–155. [PubMed] [Google Scholar]
  41. Skakkebaek N. E., Berthelsen J. G., Giwercman A., Müller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl. 1987 Feb;10(1):19–28. doi: 10.1111/j.1365-2605.1987.tb00161.x. [DOI] [PubMed] [Google Scholar]
  42. Solter D., Knowles B. B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A. 1978 Nov;75(11):5565–5569. doi: 10.1073/pnas.75.11.5565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wenk J., Andrews P. W., Casper J., Hata J., Pera M. F., von Keitz A., Damjanov I., Fenderson B. A. Glycolipids of germ cell tumors: extended globo-series glycolipids are a hallmark of human embryonal carcinoma cells. Int J Cancer. 1994 Jul 1;58(1):108–115. doi: 10.1002/ijc.2910580118. [DOI] [PubMed] [Google Scholar]
  44. de Jong B., Oosterhuis J. W., Castedo S. M., Vos A., te Meerman G. J. Pathogenesis of adult testicular germ cell tumors. A cytogenetic model. Cancer Genet Cytogenet. 1990 Sep;48(2):143–167. doi: 10.1016/0165-4608(90)90115-q. [DOI] [PubMed] [Google Scholar]
  45. el-Naggar A. K., Ro J. Y., McLemore D., Ayala A. G., Batsakis J. G. DNA ploidy in testicular germ cell neoplasms. Histogenetic and clinical implications. Am J Surg Pathol. 1992 Jun;16(6):611–618. doi: 10.1097/00000478-199206000-00009. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES